Estee Lauder posted its fiscal first quarter adjusted earnings of $1.37 per share, that exceeded the Zacks Consensus Estimate of $1.29 per share. Earnings were $1.89 per share a year ago (as reported in Zacks Equity Research) The beauty company’s revenues for the quarter fell -11% from the year-ago period, but topped the Zacks Consensus Estimate by 0.34%. While net sales for the company’s...

Procter & Gamble reported its fiscal first quarter earnings that surpassed Wall Street expectations. The consumer products company’s earnings came in at $1.57 per share, beating expectations of $1.54 per share (based on Refinitiv poll). Revenue of $20.61 billion also topped analysts’ estimate of $20.28 billion. Unfavorable foreign exchange rates eroded revenue by 6%. When excluding the impact...

Helen of Troy posted adjusted earnings of $2.41 per share for the quarter ended May 2022, which surpassed the Zacks Consensus Estimate of $1.94 per share. Earnings were $3.48 per share a year ago. The cosmetics company has topped Zacks consensus EPS estimates four times over the last four quarters. Revenues of $508.08 million exceeded the Zacks Consensus Estimate by 8.27%. Year-ago revenues...

The Estee Lauder Companies Inc. posted its fiscal third-quarter 2022 results, with earnings topping the Zacks Consensus Estimate. Revenue, however, fell short of expectations. The beauty and cosmetics company’s adjusted earnings for the quarter came in at $1.90 per share, exceeding the Zacks Consensus Estimate of $1.66. The bottom line rose +17% (up 18% at constant currency) year over year...

Estee Lauder posted second quarter earnings that fell short of analysts' forecasts. The beauty company’s earnings for the quarter came in at $2.62, behind the $2.64 expected by analysts polled by Investing.com. Revenue was $5.49 billion, vs. $5.5 billion expected by the analysts. Estee Lauder shares are down around -18% year-to-date, and about -19.55% below from its 52 week high of $374.20...

Procter & Gamble posted fiscal second-quarter earnings and revenue that beat analysts’ expectations. The consumer goods company’s earnings came in at $1.66, vs. $1.65 expected Revenue of $20.95 billion also surpassed analysts’ expectations of $20.34 billion. Net sales rose 6% to $20.95 billion, exceeding expectations of $20.34 billion. Organic revenue, which strips out the impact of foreign...

Unilever shares climbed higher on Wednesday, after the consumer goods company announced that it won't increase its offer for the consumer healthcare division of GlaxoSmithKline above £50 billion. GSK's health products business owns brands such as Panadol, Sensodyne toothpaste, and Centrum vitamins. According to GSK, Unilever's bid valued at around $68 billion has "fundamentally undervalued"...

They also slashed price target to $170 a share from $240.  Analyst Chris Carey called Clorox shares "dead money, at best, with downside."  

According to Wells Fargo analysts, Clorox sales in the professional and international segments ( "new growth drivers") missed estimates – something that makes it hard to argue for 'underappreciated' upside, as indicated by the analysts.

 

Personal care company Kimberly-Clark  reported a -12% drop in first-quarter earnings and a -5% decrease in revenue.

For the three months ended March 31, Kimberly-Clark’s  earnings came in at $1.72 a share, down from  the year-ago quarter’s $1.92 a share.

Revenue fell -5% year-over-year to $4.74 billion.

"First-quarter comparisons were impacted by COVID-19 related stock up in the year-ago period, consumer tissue category softness and commodity inflation.We also experienced temporary supply chain disruptions related to severe weather conditions in the southern part of the United States," Chairman and Chief Executive Mike Hsu  said.

For 2021, the company lowered its adjusted earnings per share projection to a range of $7.30 to $7.55, from $7.75 to $8.

Clorox shares got a rating downgrade from D.A. Davidson on concerns about an expected slowdown in sales following a possible peak in demand during the depths of the COVID-19 pandemic. The household products company’s shares were downgraded to neutral from buy by D.A. Davidson analyst Linda Bolton Weiser. She also cut her price target on the shares to $189 from $234. According to Weiser,...

Coty posted sales that were below expectations. It adjusted earnings, however, beat estimates. The beauty company’s adjusted net income came in 17 cents a share, for its fiscal second quarter ended Dec. 31, vs. 27 cents a share, in the year-ago quarter. Analysts polled by FactSet had expected per-share earnings of 7 cents. Excluding adjustments, the company had a loss of -36 cents a share vs...

All of P&G’s business units experienced growth, with gains driven by the fabric and home care unit along with the health care division.

The company now forecasts organic sales growth of 5% to 6% in fiscal 2021, up from its prior expectation of no more than 5%.It also raised its adjusted earnings forecast to 8% to 10%, up from the previous outlook of 5% to 8%.

P&G expects to buy back as much as $10 billion of its own stock during fiscal 2021, up from a prior estimate of $7 billion to $9 billion.

 

Revlon experienced a wider-than-expected  loss in the second quarter, amid covid-19 crisis. The beauty/cosmetics company’s  adjusted loss of -$1.56 per share versus the Zacks Consensus Estimate of a loss of -$1.04.Online sales accounted for 7% in the year-ago period. REV enters an Uptrend because Momentum Indicator exceeded the 0 level on August 05, 2020 This indicator signals that REV's price has momentum to move higher, since its current price moved above its price 14 days ago.

Coty Inc. announced its new CEO, following allegations that Kylie Jenner had overstated her personal wealth to inflate the value of a brand sold to the cosmetics company. Coty Chairman Peter Harf is set to replace the outgoing Pierre Laubies as CEO .The company will form a three-person executive committee intended to ensure  that Coty takes the right steps towards becoming a more profitable business and delivering on its commitments. On Friday, a report from Forbes suggested that Jenner, who sold 51% of her 'Kyle Cosmetics' line to Coty last year for around $600 million, had inflated its value to the media. Jenner said the report was full of "a number of inaccurate statements and unproven assumptions.The odds of a continued Downtrend are 75%. The Aroon Indicator entered a Downtrend today.

Colgate-Palmolive stock got a rating downgrade from analysts at Bank of America Securities. BofA Securities cut their rating on the shares of  the consumer products’ maker to neutral from buy. BofA analyst Olivia Tong lowered her price target on the shares  to $74 a share from $77 (as reported in Bloomberg ).Tong  also indicated that Colgate-Palmolive might  face even more challenging conditions next year, and that the situation could necessitate another year of outsized investment.  

Coty has decided to spend $600 million for a majority stake in Kylie Jenner’s cosmetics brand. The beauty company plans it to invest the amount for acquiring  a 51% stake in Kylie Cosmetics. Under the deal, Jenner and her team will lead the social media and product communications segments, while Coty will work on global promotion of her brand.The company also revealed a $3 billion write down in value of brands it acquired in 2015 from Procter & Gamble, which included CoverGirl and Clairol. Coty’s investment in Kylie Cosmetics  is expected to close in the third quarter of 2020. Coty called the transaction a "key milestone" for the company.  

Estee Lauder shares declined on Thursday, after the cosmetics & skincare company reported better-than-anticipated earnings, but provided guidance below expectation. For the three months ended Sept. 30, the company’s earnings came in at $1.61 a share, exceeding the $1.60 a share expected by analysts.It is also higher than  analysts' forecasts. CEO Fabrizio Freda indicated that strong international sales, particularly in China and other emerging markets, as well as within the company's skin care category, travel retail and online channels bolstered earnings for the quarter. However, Estee Lauder now expects second-quarter earnings per share in the range of $1.83 to $1.86, and full-year per-share earnings of $5.85 to  $5.93 - both the ranges are below analysts' forecasts.

Newell Brands shares climbed Monday, following a hike in rating and increase in price target from SunTrust. Analysts at SunTrust raised the their rating on the consumer & commercial products maker’s stock to buy from hold.They also increased their price target on the shares to $25 from $15 a share – thereby representing a potential 36% upside from the stock's closing price Friday of $18.31.  Analyst Bill Chappell believes that the worst in business trends is has bottomed out, and that turnaround efforts are gaining traction for the company.

Nu Skin Enterprises shares fell as much as -20% on Wednesday, after the company expressed concerns over headwinds from China’s increased scrutiny on health products. The company, which develops and sells personal care products, revealed that it is adjusting its guidance for the year, mainly due to a dampened revenue outlook in Mainland China following the government’s 100-day campaign to review and scrutinize the health products and direct selling industries. The increased scrutiny on the direct selling industry has reportedly led to a tightening of regulations on sales meetings - something that could adversely affect customer sentiment, as hinted by NU Skin CEO Ritch Wood.China accounted for 33% of Nu Skin’s revenue in 2018. The company is scheduled to release its second quarter earnings reports on August 6.

Shares of Avon Products surged almost 12% on Wednesday as Brazilian cosmetic maker Natura Cosmeticos SA moved another notch closer to acquiring the U.S. company via an all-stock deal to unite two of Brazil’s most popular makeup brands.This will likely move Natura closer to its goal of being a global player. In the said deal, Natura would become the majority shareholder in the 133-year-old U.S. group, which has a market capitalization of about $1.4 billion and is most popular for its direct sales model. Following the news of the deal, Avon shares were up 11% bringing their rise this year to 137%. On the other hand, Natura accumulated a 32% rise this year. Two years ago, Natura acquired The Body Shop from L’Oreal for nearly $1 billion.